The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract

Author(s): Benjamin Rahmani, Jason Gandhi, Gunjan Joshi, Noel L. Smith, Inefta Reid*, Sardar Ali Khan*

Journal Name: Current Diabetes Reviews

Volume 16 , Issue 9 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: The increasing prevalence of diabetes mellitus worldwide continues to pose a heavy burden. Though its gastrointestinal impact is appropriately recognized, the lesser known associations may be overlooked.

Objective: We aim to review the negative implications of diabetes on the gallbladder and the biliary tract.

Methods: A MEDLINE® database search of literature was conducted with emphasis on the previous five years, combining keywords such as "diabetes," "gallbladder," and "biliary".

Results: The association of diabetes to the formation of gallstones, gallbladder cancer, and cancer of the biliary tract are discussed along with diagnosis and treatment.

Conclusion: Though we uncover the role of diabetic neuropathy in gallbladder and biliary complications, the specific individual diabetic risk factors behind these developments is unclear. Also, in addition to diabetes control and surgical gallbladder management, the treatment approach also requires further focus.

Keywords: Gallstones, gallbladder disease, gallbladder cancer, cholangiocarcinoma, gastroparesis, diabetes mellitus.

[1]
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-S20.
[http://dx.doi.org/10.2337/diacare.26.2007.S5] [PMID: 12502614]
[2]
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28(12): 1039-57.
[http://dx.doi.org/10.2337/diab.28.12.1039] [PMID: 510803]
[3]
American Diabetes Association Classification and diagnosis of diabetes. Diabetes Care 2015; 38(Suppl.): S8-S16.
[http://dx.doi.org/10.2337/dc15-S005] [PMID: 25537714]
[4]
Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331(21): 1428-36.
[http://dx.doi.org/10.1056/NEJM199411243312107] [PMID: 7969282]
[5]
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298(5870): 167-9.
[http://dx.doi.org/10.1038/298167a0] [PMID: 7045690]
[6]
Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986; 35(8): 894-8.
[http://dx.doi.org/10.2337/diab.35.8.894] [PMID: 3525287]
[7]
Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89(1): 283-92.
[http://dx.doi.org/10.1172/JCI115573] [PMID: 1370298]
[8]
Christie MR, Tun RY, Lo SS, et al. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes 1992; 41(7): 782-7.
[http://dx.doi.org/10.2337/diab.41.7.782] [PMID: 1612192]
[9]
Schott M, Schatz D, Atkinson M, et al. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmun 1994; 7(6): 865-72.
[http://dx.doi.org/10.1006/jaut.1994.1070] [PMID: 7888042]
[10]
Schmidli RS, Colman PG, Harrison LC. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? J Autoimmun 1994; 7(6): 873-9.
[http://dx.doi.org/10.1006/jaut.1994.1071] [PMID: 7888043]
[11]
Myers MA, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995; 44(11): 1290-5.
[http://dx.doi.org/10.2337/diab.44.11.1290] [PMID: 7589826]
[12]
Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996; 93(13): 6367-70.
[http://dx.doi.org/10.1073/pnas.93.13.6367] [PMID: 8692821]
[13]
Lu J, Li Q, Xie H, et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996; 93(6): 2307-11.
[http://dx.doi.org/10.1073/pnas.93.6.2307] [PMID: 8637868]
[14]
Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 1976; 60(1): 80-8.
[http://dx.doi.org/10.1016/0002-9343(76)90536-2] [PMID: 814810]
[15]
Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 1982; 243(1): E15-30.
[PMID: 7046470]
[16]
Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979; 28(11): 1086-96.
[http://dx.doi.org/10.1016/0026-0495(79)90146-X] [PMID: 386029]
[17]
Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(Suppl. 1): S67-74.
[http://dx.doi.org/10.2337/dc13-S067] [PMID: 23264425]
[18]
Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248(3 Pt 1): E286-91.
[PMID: 3883799]
[19]
Kolterman OG, Gray RS, Griffin J, et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 1981; 68(4): 957-69.
[http://dx.doi.org/10.1172/JCI110350] [PMID: 7287908]
[20]
Al-Hussaini AA, Alenizi AS, AlZahrani MD, Sulaiman NM, Khan M. Is there an association between type 1 diabetes in children and gallbladder stones formation? Saudi J Gastroenterol 2013; 19(2): 86-8.
[http://dx.doi.org/10.4103/1319-3767.108482] [PMID: 23481135]
[21]
Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36(4): 523-34.
[http://dx.doi.org/10.2337/diab.36.4.523] [PMID: 3817306]
[22]
Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18(2): 258-68.
[http://dx.doi.org/10.2337/diacare.18.2.258] [PMID: 7729308]
[23]
Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16(4): 642-52.
[http://dx.doi.org/10.2337/diacare.16.4.642] [PMID: 8462395]
[24]
Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol 2014; 126: 63-79.
[http://dx.doi.org/10.1016/B978-0-444-53480-4.00006-0] [PMID: 25410215]
[25]
Neil HA, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: The prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989; 6(1): 20-4.
[http://dx.doi.org/10.1111/j.1464-5491.1989.tb01133.x] [PMID: 2522369]
[26]
Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43(4): 817-24.
[http://dx.doi.org/10.1212/WNL.43.4.817] [PMID: 8469345]
[27]
Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MI. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 1996; 45(3): 308-15.
[http://dx.doi.org/10.2337/diab.45.3.308] [PMID: 8593935]
[28]
Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49(193): 95-108.
[PMID: 7433630]
[29]
Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150(6): 1218-22.
[http://dx.doi.org/10.1001/archinte.1990.00390180056009] [PMID: 2353855]
[30]
Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26(6): 1895-901.
[http://dx.doi.org/10.2337/diacare.26.6.1895] [PMID: 12766130]
[31]
Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39(7): 802-6.
[http://dx.doi.org/10.2337/diab.39.7.802] [PMID: 2354747]
[32]
Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990; 75(278): 635-46.
[PMID: 2217668]
[33]
O’Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 1991; 79(290): 495-502.
[PMID: 1946930]
[34]
Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10(9): 820-4.
[http://dx.doi.org/10.1111/j.1464-5491.1993.tb00173.x] [PMID: 8281726]
[35]
Chen HS, Hwu CM, Kuo BI, et al. Abnormal cardiovascular reflex tests are predictors of mortality in Type 2 diabetes mellitus. Diabet Med 2001; 18(4): 268-73.
[http://dx.doi.org/10.1046/j.1464-5491.2001.00442.x] [PMID: 11437856]
[36]
Gerritsen J, Dekker JM, TenVoorde BJ, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The Hoorn Study. Diabetes Care 2001; 24(10): 1793-8.
[http://dx.doi.org/10.2337/diacare.24.10.1793] [PMID: 11574444]
[37]
Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: The EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31(7): 1360-6.
[http://dx.doi.org/10.2337/dc08-0107] [PMID: 18375412]
[38]
Bennett T, Hosking DJ, Hampton JR. Cardiovascular control in diabetes mellitus. BMJ 1975; 2(5971): 585-7.
[http://dx.doi.org/10.1136/bmj.2.5971.585] [PMID: 1131623]
[39]
Lloyd-Mostyn RH, Watkins PJ. Defective innervation of heart in diabetic autonomic neuropathy. BMJ 1975; 3(5974): 15-7.
[http://dx.doi.org/10.1136/bmj.3.5974.15] [PMID: 1131653]
[40]
Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet 1981; 1(8213): 183-6.
[http://dx.doi.org/10.1016/S0140-6736(81)90061-1] [PMID: 6109858]
[41]
Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus: Diagnostic and prognostic value. Circulation 2006; 113(4): 583-92.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.584524] [PMID: 16449735]
[42]
Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356(8): 820-9.
[http://dx.doi.org/10.1056/NEJMcp062614] [PMID: 17314341]
[43]
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: Management of gastroparesis. Am J Gastroenterol 2013; 108(1): 18-37.
[http://dx.doi.org/10.1038/ajg.2012.373] [PMID: 23147521]
[44]
Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes 2013; 62(8): 2667-73.
[http://dx.doi.org/10.2337/db12-1706] [PMID: 23881199]
[45]
Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48(4): 797-812.
[http://dx.doi.org/10.7326/0003-4819-48-4-797] [PMID: 13521605]
[46]
Vogelberg KH, Rathmann W, Helbig G. Sonographic examination of gastric motility in diabetics with autonomic neuropathy. Diabetes Res 1987; 5(4): 175-9.
[PMID: 3311557]
[47]
Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32(3): 151-9.
[http://dx.doi.org/10.1007/BF00265086] [PMID: 2753246]
[48]
Parkman HP, Schwartz SS. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med 1987; 147(8): 1477-80.
[http://dx.doi.org/10.1001/archinte.1987.00370080113021] [PMID: 3632153]
[49]
Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 1996; 271(5 Pt 1): G814-9.
[PMID: 8944695]
[50]
Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24(2): 371-81.
[http://dx.doi.org/10.2337/diacare.24.2.371] [PMID: 11213895]
[51]
Ma J, Rayner CK, Jones KL, Horowitz M. Diabetic gastroparesis: Diagnosis and management. Drugs 2009; 69(8): 971-86.
[http://dx.doi.org/10.2165/00003495-200969080-00003] [PMID: 19496627]
[52]
Horowitz M, Jones KL, Rayner CK, Read NW. ‘Gastric’ hypoglycaemia--an important concept in diabetes management. Neurogastroenterol Motil 2006; 18(6): 405-7.
[http://dx.doi.org/10.1111/j.1365-2982.2006.00804.x] [PMID: 16700718]
[53]
Battle WM, Snape WJ Jr, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology 1980; 79(6): 1217-21.
[http://dx.doi.org/10.1016/0016-5085(80)90916-6] [PMID: 7439629]
[54]
Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98(3): 378-84.
[http://dx.doi.org/10.7326/0003-4819-98-3-378] [PMID: 6402969]
[55]
Maleki D, Locke GR III, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160(18): 2808-16.
[http://dx.doi.org/10.1001/archinte.160.18.2808] [PMID: 11025791]
[56]
Kempler P, Amarenco G, Freeman R, et al. Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes. Diabetes Metab Res Rev 2011; 27(7): 665-77.
[http://dx.doi.org/10.1002/dmrr.1223] [PMID: 21748841]
[57]
Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993; 68(7): 691-702.
[http://dx.doi.org/10.1016/S0025-6196(12)60606-5] [PMID: 8350642]
[58]
Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol 1999; 94(8): 2165-70.
[http://dx.doi.org/10.1111/j.1572-0241.1999.01289.x] [PMID: 10445544]
[59]
Schiller LR, Santa Ana CA, Schmulen AC, Hendler RS, Harford WV, Fordtran JS. Pathogenesis of fecal incontinence in diabetes mellitus: Evidence for internal-anal-sphincter dysfunction. N Engl J Med 1982; 307(27): 1666-71.
[http://dx.doi.org/10.1056/NEJM198212303072702] [PMID: 7144865]
[60]
Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med 1985; 102(2): 197-9.
[http://dx.doi.org/10.7326/0003-4819-102-2-197] [PMID: 3966758]
[61]
Chen CH, Lin CL, Hsu CY, Kao CH. Association Between Type I and II Diabetes With Gallbladder Stone Disease. Front Endocrinol (Lausanne) 2018; 9: 720.
[http://dx.doi.org/10.3389/fendo.2018.00720] [PMID: 30555418]
[62]
Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon) 2014; 42(12): 698-702.
[http://dx.doi.org/10.1016/j.mpmed.2014.09.007] [PMID: 25568613]
[63]
Qi L, Tian Y, Chen Y. Gall bladder: The metabolic orchestrator. Diabetes Metab Res Rev 2019; 35(5)e3140
[http://dx.doi.org/10.1002/dmrr.3140] [PMID: 30770629]
[64]
Jiménez E, Sánchez B, Farina A, Margolles A, Rodríguez JM. Characterization of the bile and gall bladder microbiota of healthy pigs. MicrobiologyOpen 2014; 3(6): 937-49.
[http://dx.doi.org/10.1002/mbo3.218] [PMID: 25336405]
[65]
Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29(4): 625-51.
[http://dx.doi.org/10.1016/j.femsre.2004.09.003] [PMID: 16102595]
[66]
Hofmann AF, Eckmann L. How bile acids confer gut mucosal protection against bacteria. Proc Natl Acad Sci USA 2006; 103(12): 4333-4.
[http://dx.doi.org/10.1073/pnas.0600780103] [PMID: 16537368]
[67]
Inagaki T, Moschetta A, Lee YK, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA 2006; 103(10): 3920-5.
[http://dx.doi.org/10.1073/pnas.0509592103] [PMID: 16473946]
[68]
Deutschmann K, Reich M, Klindt C, et al. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochim Biophys Acta Mol Basis Dis 2018; 1864(4 Pt B): 1319-25.
[http://dx.doi.org/10.1016/j.bbadis.2017.08.021] [PMID: 28844960]
[69]
Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 2008; 65(16): 2461-83.
[http://dx.doi.org/10.1007/s00018-008-7568-6] [PMID: 18488143]
[70]
Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273(16): 10046-50.
[http://dx.doi.org/10.1074/jbc.273.16.10046] [PMID: 9545351]
[71]
Housset C, Chrétien Y, Debray D, Chignard N. Functions of the Gallbladder. Compr Physiol 2016; 6(3): 1549-77.
[http://dx.doi.org/10.1002/cphy.c150050] [PMID: 27347902]
[72]
Pazzi P, Scagliarini R, Gamberini S, Pezzoli A. Review article: gall-bladder motor function in diabetes mellitus. Aliment Pharmacol Ther 2000; 14(Suppl. 2): 62-5.
[http://dx.doi.org/10.1046/j.1365-2036.2000.014s2062.x] [PMID: 10903007]
[73]
Lieber MM. The incidence of gallstones and their correlation with other diseases. Ann Surg 1952; 135(3): 394-405.
[http://dx.doi.org/10.1097/00000658-195203000-00011] [PMID: 14903868]
[74]
Newman HF, Northup JD. The autopsy incidence of gallstones. Surg Gynecol Obstet 1959; 109(1): 1-13.
[PMID: 13668853]
[75]
De Santis A, Attili AF, Ginanni Corradini S, et al. Gallstones and diabetes: A case-control study in a free-living population sample. Hepatology 1997; 25(4): 787-90.
[http://dx.doi.org/10.1002/hep.510250401] [PMID: 9096577]
[76]
Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997; 26(4): 809-18.
[http://dx.doi.org/10.1002/hep.510260401] [PMID: 9328297]
[77]
Attili AF, Pazzi P, Galeazzi R. Prevalence of previously undiagnosed gallstones in a population with multiple risk factors. Dig Dis Sci 1995; 40(8): 1770-4.
[http://dx.doi.org/10.1007/BF02212700] [PMID: 7648978]
[78]
Keplinger KM, Bloomston M. Anatomy and embryology of the biliary tract. Surg Clin North Am 2014; 94(2): 203-17.
[http://dx.doi.org/10.1016/j.suc.2014.01.001] [PMID: 24679417]
[79]
Kune GA. Surgical anatomy of common bile duct. Arch Surg 1964; 89: 995-1004.
[http://dx.doi.org/10.1001/archsurg.1964.01320060063012] [PMID: 14208474]
[80]
Chaib E, Kanas AF, Galvão FH, D’Albuquerque LA. Bile duct confluence: Anatomic variations and its classification. Surg Radiol Anat 2014; 36(2): 105-9.
[http://dx.doi.org/10.1007/s00276-013-1157-6] [PMID: 23817807]
[81]
Strazzabosco M, Fabris L. Development of the bile ducts: essentials for the clinical hepatologist. J Hepatol 2012; 56(5): 1159-70.
[http://dx.doi.org/10.1016/j.jhep.2011.09.022] [PMID: 22245898]
[82]
Yoon HA, Noh MH, Kim BG, et al. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-30.
[http://dx.doi.org/10.3748/wjg.v17.i35.4023] [PMID: 22046092]
[83]
White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 2012; 142(2): 219-32.
[http://dx.doi.org/10.1053/j.gastro.2011.12.001] [PMID: 22155636]
[84]
Shen FZ, Zhang BY, Feng YJ, et al. Current research in perineural invasion of cholangiocarcinoma. J Exp Clin Cancer Res 2010; 29: 24.
[http://dx.doi.org/10.1186/1756-9966-29-24] [PMID: 20219134]
[85]
Zong Y, Stanger BZ. Molecular mechanisms of bile duct development. Int J Biochem Cell Biol 2011; 43(2): 257-64.
[http://dx.doi.org/10.1016/j.biocel.2010.06.020] [PMID: 20601079]
[86]
Lavoie B, Balemba OB, Godfrey C, et al. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol 2010; 588(Pt 17): 3295-305.
[http://dx.doi.org/10.1113/jphysiol.2010.192146] [PMID: 20624794]
[87]
Watkins PJ, Thomas PK. Diabetes mellitus and the nervous system. J Neurol Neurosurg Psychiatry 1998; 65(5): 620-32.
[http://dx.doi.org/10.1136/jnnp.65.5.620] [PMID: 9810929]
[88]
Stone BG, Gavaler JS, Belle SH, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 1988; 95(1): 170-6.
[http://dx.doi.org/10.1016/0016-5085(88)90307-1] [PMID: 3371612]
[89]
Carbajo MA, Martín del Omo JC, Blanco JI, et al. Congenital malformations of the gallbladder and cystic duct diagnosed by laparoscopy: high surgical risk. JSLS 1999; 3(4): 319-21.
[PMID: 10694079]
[90]
Hassan S, Young AL, Farooq M, Pai D, Gough M. Accessory gallbladder: a new anatomical variation arising from both left and right hepatic ducts. Ann R Coll Surg Engl 2012; 94(6): e204-5.
[http://dx.doi.org/10.1308/003588412X13373405385052] [PMID: 22943323]
[91]
Gielkens HA, van Oostayen JA, Frölich M, Biemond I, Lamers CB, Masclee AA. Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia. Scand J Gastroenterol 1998; 33(10): 1074-9.
[http://dx.doi.org/10.1080/003655298750026787] [PMID: 9829363]
[92]
de Boer SY, Masclee AA, Jebbink MC, et al. Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans. Gut 1993; 34(8): 1128-32.
[http://dx.doi.org/10.1136/gut.34.8.1128] [PMID: 8174967]
[93]
Fiorucci S, Scionti L, Bosso R, et al. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 1992; 37(11): 1671-7.
[http://dx.doi.org/10.1007/BF01299857] [PMID: 1425065]
[94]
Hahm JS, Park JY, Park KG, Ahn YH, Lee MH, Park KN. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol 1996; 91(11): 2391-4.
[PMID: 8931423]
[95]
Chapman BA, Chapman TM, Frampton CM, et al. Gallbladder volume: comparison of diabetics and controls. Dig Dis Sci 1998; 43(2): 344-8.
[http://dx.doi.org/10.1023/A:1018810523399] [PMID: 9512128]
[96]
Keshavarzian A, Dunne M, Iber FL. Gallbladder volume and emptying in insulin-requiring male diabetics. Dig Dis Sci 1987; 32(8): 824-8.
[http://dx.doi.org/10.1007/BF01296703] [PMID: 3301231]
[97]
Fiorucci S, Bosso R, Scionti L, et al. Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy. Dig Dis Sci 1990; 35(9): 1089-97.
[http://dx.doi.org/10.1007/BF01537580] [PMID: 2202570]
[98]
Mitsukawa T, Takemura J, Ohgo S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol 1990; 85(8): 981-5.
[PMID: 2375326]
[99]
Palasciano G, Portincasa P, Belfiore A, et al. Gallbladder volume and emptying in diabetics: The role of neuropathy and obesity. J Intern Med 1992; 231(2): 123-7.
[http://dx.doi.org/10.1111/j.1365-2796.1992.tb00512.x] [PMID: 1541933]
[100]
Wedmann B, Dröge C, Amoiridis G, Schmidt-Heinevetter G, Wegener M, Ricken D. Gallbladder motility in diabetic patients with and without cardiovascular neuropathy. Z Gastroenterol 1992; 30(8): 519-24.
[PMID: 1413934]
[101]
Catnach SM, Ballinger AB, Stevens M, et al. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. Gut 1993; 34(8): 1123-7.
[http://dx.doi.org/10.1136/gut.34.8.1123] [PMID: 8174966]
[102]
de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994; 37(1): 75-81.
[http://dx.doi.org/10.1007/BF00428781] [PMID: 8150234]
[103]
Meguro T, Shimosegawa T, Satoh A, et al. Gallbladder emptying and cholecystokinin and pancreatic polypeptide responses to a liquid meal in patients with diabetes mellitus. J Gastroenterol 1997; 32(5): 628-34.
[http://dx.doi.org/10.1007/BF02934112] [PMID: 9349988]
[104]
Shaw SJ, Hajnal F, Lebovitz Y, et al. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 1993; 38(3): 490-6.
[http://dx.doi.org/10.1007/BF01316504] [PMID: 8444081]
[105]
Kao CH, Tsou CT, Wang SJ, Yeh SH. The evaluation of gallbladder function by quantitative radionuclide cholescintigraphy in patients with noninsulin-dependent diabetes mellitus. Nucl Med Commun 1993; 14(10): 868-72.
[http://dx.doi.org/10.1097/00006231-199310000-00006] [PMID: 8233230]
[106]
Lanzini A, Jazrawi RP, Northfield TC. Simultaneous quantitative measurements of absolute gallbladder storage and emptying during fasting and eating in humans. Gastroenterology 1987; 92(4): 852-61.
[http://dx.doi.org/10.1016/0016-5085(87)90957-7] [PMID: 3454164]
[107]
Howard PJ, Murphy GM, Dowling RH. Gall bladder emptying patterns in response to a normal meal in healthy subjects and patients with gall stones: ultrasound study. Gut 1991; 32(11): 1406-11.
[http://dx.doi.org/10.1136/gut.32.11.1406] [PMID: 1752478]
[108]
Jazrawi RP, Pazzi P, Petroni ML, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology 1995; 109(2): 582-91.
[http://dx.doi.org/10.1016/0016-5085(95)90348-8] [PMID: 7615209]
[109]
Laakso M, Suhonen M, Julkunen R, Pyörälä K. Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: A case control study. Gut 1990; 31(3): 344-7.
[http://dx.doi.org/10.1136/gut.31.3.344] [PMID: 2182400]
[110]
Pazzi P, Trevisani L, Sartori S, Sighinolfi D, Alvisi V. Diabetes and cholelithiasis. Gut 1990; 31(12): 1422-3.
[http://dx.doi.org/10.1136/gut.31.12.1422] [PMID: 2265792]
[111]
Gielkens HA, Lam WF, Coenraad M, et al. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998; 28(4): 595-602.
[http://dx.doi.org/10.1016/S0168-8278(98)80282-1] [PMID: 9566827]
[112]
Oster-Jørgensen E, Pedersen SA, Larsen ML. The influence of induced hyperglycaemia on gastric emptying rate in healthy humans. Scand J Clin Lab Invest 1990; 50(8): 831-6.
[http://dx.doi.org/10.3109/00365519009104949] [PMID: 2084820]
[113]
Catnach SM, Fairclough PD, Trembath RC, et al. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992; 102(6): 2071-6.
[http://dx.doi.org/10.1016/0016-5085(92)90334-U] [PMID: 1587426]
[114]
Halpin V. Acute cholecystitis. BMJ Clin Evid 2014; 2014.
[115]
Balemba OB, Salter MJ, Mawe GM. Innervation of the extrahepatic biliary tract. Anat Rec A Discov Mol Cell Evol Biol 2004; 280(1): 836-47.
[http://dx.doi.org/10.1002/ar.a.20089] [PMID: 15382017]
[116]
Mawe GM. Nerves and hormones interact to control gallbladder function. News Physiol Sci 1998; 13: 84-90.
[http://dx.doi.org/10.1152/physiologyonline.1998.13.2.84] [PMID: 11390768]
[117]
Ward FM, Bodger K, Daly MJ, Heatley RV. Clinical economics review: medical management of inflammatory bowel disease. Aliment Pharmacol Ther 1999; 13(1): 15-25.
[http://dx.doi.org/10.1046/j.1365-2036.1999.00437.x] [PMID: 9892875]
[118]
Thuneberg L. One hundred years of interstitial cells of Cajal. Microsc Res Tech 1999; 47(4): 223-38.
[http://dx.doi.org/10.1002/(SICI)1097-0029(19991115)47:4<223:AID-JEMT2>3.0.CO;2-C] [PMID: 10602284]
[119]
Thuneberg L, Peters S. Toward a concept of stretch-coupling in smooth muscle. I. Anatomy of intestinal segmentation and sleeve contractions. Anat Rec 2001; 262(1): 110-24.
[http://dx.doi.org/10.1002/1097-0185(20010101)262:1<110:AID-AR1016>3.0.CO;2-0] [PMID: 11146434]
[120]
Struller F, Weinreich FJ, Horvath P, et al. Peritoneal innervation: embryology and functional anatomy. Pleura Peritoneum 2017; 2(4): 153-61.
[http://dx.doi.org/10.1515/pp-2017-0024] [PMID: 30911646]
[121]
Gaur C, Mathur A, Agarwal A, Verma K, Jain R, Swaroop A. Diabetic autonomic neuropathy causing gall bladder dysfunction. J Assoc Physicians India 2000; 48(6): 603-5.
[PMID: 11273539]
[122]
Agashe S, Petak S. Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist DeBakey Cardiovasc J 2018; 14(4): 251-6.
[PMID: 30788010]
[123]
Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014; 5(1): 17-39.
[http://dx.doi.org/10.4239/wjd.v5.i1.17] [PMID: 24567799]
[124]
Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27(7): 639-53.
[http://dx.doi.org/10.1002/dmrr.1239] [PMID: 21695768]
[125]
Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006; 21(11): 1737-43.
[http://dx.doi.org/10.1111/j.1440-1746.2006.04381.x] [PMID: 16984599]
[126]
Gurusamy KS, Davidson BR, Gallstones BMJ. 2014. ; 348: g2669.
[http://dx.doi.org/10.1136/bmj.g2669] [PMID: 24755732]
[127]
Ross M, Brown M, McLaughlin K, et al. Emergency physician-performed ultrasound to diagnose cholelithiasis: a systematic review. Acad Emerg Med 2011; 18(3): 227-35.
[http://dx.doi.org/10.1111/j.1553-2712.2011.01012.x] [PMID: 21401784]
[128]
Salek J, Livote E, Sideridis K, Bank S. Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis. J Clin Gastroenterol 2009; 43(2): 171-5.
[http://dx.doi.org/10.1097/MCG.0b013e318157c62c] [PMID: 18769362]
[129]
Berger MY, van der Velden JJ, Lijmer JG, de Kort H, Prins A, Bohnen AM. Abdominal symptoms: do they predict gallstones? A systematic review. Scand J Gastroenterol 2000; 35(1): 70-6.
[http://dx.doi.org/10.1080/003655200750024560] [PMID: 10672838]
[130]
Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. Hepatology 1995; 21(3): 655-60.
[http://dx.doi.org/10.1002/hep.1840210309] [PMID: 7875663]
[131]
Del Favero G, Caroli A, Meggiato T, et al. Natural history of gallstones in non-insulin-dependent diabetes mellitus. A prospective 5-year follow-up. Dig Dis Sci 1994; 39(8): 1704-7.
[http://dx.doi.org/10.1007/BF02087780] [PMID: 8050321]
[132]
Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg 2004; 91(6): 734-8.
[http://dx.doi.org/10.1002/bjs.4547] [PMID: 15164444]
[133]
Portincasa P, Moschetta A, Petruzzelli M, Palasciano G, Di Ciaula A, Pezzolla A. Gallstone disease: Symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol 2006; 20(6): 1017-29.
[http://dx.doi.org/10.1016/j.bpg.2006.05.005] [PMID: 17127185]
[134]
Coucke EM, Lopez PP. Biliary ObstructionStat Pearls. Treasure Island (FL) 2019.
[135]
Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118(7): 1591-602.
[http://dx.doi.org/10.1002/ijc.21683] [PMID: 16397865]
[136]
Diehl AK, Sugarek NJ, Todd KH. Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis. Am J Med 1990; 89(1): 29-33.
[http://dx.doi.org/10.1016/0002-9343(90)90094-T] [PMID: 2368790]
[137]
Tsai MS, Lee PH, Lin CL, Peng CL, Kao CH. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases. Int J Cancer 2015; 136(10): 2409-17.
[http://dx.doi.org/10.1002/ijc.29292] [PMID: 25348605]
[138]
Chen YK, Yeh JH, Lin CL, et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol 2014; 49(5): 923-31.
[http://dx.doi.org/10.1007/s00535-013-0846-6] [PMID: 23807230]
[139]
Chapman BA, Wilson IR, Frampton CM, et al. Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 1996; 41(11): 2222-8.
[http://dx.doi.org/10.1007/BF02071404] [PMID: 8943976]
[140]
Ludvigsson JF, Bergquist A, Montgomery SM, Bahmanyar S. Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis. J Hepatol 2014; 60(4): 802-8.
[http://dx.doi.org/10.1016/j.jhep.2013.11.017] [PMID: 24291242]
[141]
Tsai MS, Li YF, Lin CL, et al. Long-term risk of acute coronary syndrome in patients with cholangitis: a 13-year nationwide cohort study. Eur J Intern Med 2014; 25(5): 444-8.
[http://dx.doi.org/10.1016/j.ejim.2014.03.015] [PMID: 24713207]
[143]
Agunloye AM, Adebakin AM, Adeleye JO, Ogunseyinde AO. Ultrasound prevalence of gallstone disease in diabetic patients at Ibadan, Nigeria. Niger J Clin Pract 2013; 16(1): 71-5.
[http://dx.doi.org/10.4103/1119-3077.106770] [PMID: 23377475]
[144]
Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol 2007; 102(3): 558-62.
[http://dx.doi.org/10.1111/j.1572-0241.2006.01019.x] [PMID: 17156142]
[145]
Fargo MV, Grogan SP, Saguil A. Evaluation of Jaundice in Adults. Am Fam Physician 2017; 95(3): 164-8.
[PMID: 28145671]
[146]
Winger J, Michelfelder A. Diagnostic approach to the patient with jaundice. Prim Care 2011; 38(3): 469-82. [viii.
[http://dx.doi.org/10.1016/j.pop.2011.05.004] [PMID: 21872092]
[147]
Leake RA. Clinical diagnosis of gall-bladder disease. J R Coll Gen Pract 1985; 35(277): 372-4.
[PMID: 4020753]
[148]
Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44(1): 3-15.
[http://dx.doi.org/10.1007/s001250051573] [PMID: 11206408]
[149]
Varadarajan P. Infantile onset diabetes mellitus in developing countries - India. World J Diabetes 2016; 7(6): 134-41.
[http://dx.doi.org/10.4239/wjd.v7.i6.134] [PMID: 27022444]
[150]
Concepcion JP, Reh CS, Daniels M, et al. Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6. Pediatr Diabetes 2014; 15(1): 67-72.
[http://dx.doi.org/10.1111/pedi.12063] [PMID: 23914949]
[151]
de Boer SY, Masclee AA, Lamers CB. Effect of hyperglycemia on gastrointestinal and gallbladder motility. Scand J Gastroenterol Suppl 1992; 194: 13-8.
[http://dx.doi.org/10.3109/00365529209096020] [PMID: 1298041]
[152]
Gonzalez-Regueiro JA, Moreno-Castañeda L, Uribe M, Chávez-Tapia NC. The role of bile acids in glucose metabolism and their relation with diabetes Ann Hepatol 2017; 16-21. 16(Suppl. 1: s3-105.):
[http://dx.doi.org/10.5604/01.3001.0010.5494]
[153]
Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 2017; 13(10): 572-87.
[http://dx.doi.org/10.1038/nrendo.2017.80] [PMID: 28731034]
[154]
Titchenell PM, Lazar MA, Birnbaum MJ. Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends Endocrinol Metab 2017; 28(7): 497-505.
[http://dx.doi.org/10.1016/j.tem.2017.03.003] [PMID: 28416361]
[155]
Madura JA, Loomis RC, Harris RA, Grosfeld J, Tompkins RK. Relationship of obesity to bile lithogenicity in man. Ann Surg 1979; 189(1): 106-11.
[http://dx.doi.org/10.1097/00000658-197901000-00020] [PMID: 758854]
[156]
Heller F, Bouchier IA. Cholesterol and bile salt studies on the bile of patients with cholesterol gallstones. Gut 1973; 14(2): 83-8.
[http://dx.doi.org/10.1136/gut.14.2.83] [PMID: 4696536]
[157]
Holzbach RT, Marsh M, Olszewski M, Holan K. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973; 52(6): 1467-79.
[http://dx.doi.org/10.1172/JCI107321] [PMID: 4703231]
[158]
Ren HB, Yu T, Liu C, Li YQ. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 2011; 22(6): 837-47.
[http://dx.doi.org/10.1007/s10552-011-9754-3] [PMID: 21424210]
[159]
Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24(2): 115-25.
[http://dx.doi.org/10.1055/s-2004-828889] [PMID: 15192785]
[160]
Jin F, Devesa SS, Chow WH, et al. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer 1999; 83(4): 435-40.
[http://dx.doi.org/10.1002/(SICI)1097-0215(19991112)83:4<435:AID-IJC1>3.0.CO;2-J] [PMID: 10508476]
[161]
Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13(10): 1505-15.
[http://dx.doi.org/10.3748/wjg.v13.i10.1505] [PMID: 17461441]
[162]
Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007; 96(9): 1457-61.
[http://dx.doi.org/10.1038/sj.bjc.6603703] [PMID: 17375043]
[163]
Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 2007; 5(10): 1221-8.
[http://dx.doi.org/10.1016/j.cgh.2007.05.020] [PMID: 17689296]
[164]
Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102(5): 1016-21.
[http://dx.doi.org/10.1111/j.1572-0241.2007.01104.x] [PMID: 17324130]
[165]
Welzel TM, Mellemkjaer L, Gloria G, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 2007; 120(3): 638-41.
[http://dx.doi.org/10.1002/ijc.22283] [PMID: 17109384]
[166]
Frasca F, Pandini G, Sciacca L, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008; 114(1): 23-37.
[http://dx.doi.org/10.1080/13813450801969715] [PMID: 18465356]
[167]
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4(8): 579-91.
[http://dx.doi.org/10.1038/nrc1408] [PMID: 15286738]
[168]
Andersen DK, Korc M, Petersen GM, et al. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes 2017; 66(5): 1103-10.
[http://dx.doi.org/10.2337/db16-1477] [PMID: 28507210]
[169]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66(1): 7-30.
[http://dx.doi.org/10.3322/caac.21332] [PMID: 26742998]
[170]
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74(11): 2913-21.
[http://dx.doi.org/10.1158/0008-5472.CAN-14-0155] [PMID: 24840647]
[171]
Leclerc E, Vetter SW. The role of S100 proteins and their receptor RAGE in pancreatic cancer. Biochim Biophys Acta 2015; 1852(12): 2706-11.
[http://dx.doi.org/10.1016/j.bbadis.2015.09.022] [PMID: 26435083]
[172]
Burgstaller M, Barthel S, Kasper H. Diabetic gastroparesis and gallbladder disease. Ultrasound diagnosis after multiple-component meals. Dtsch Med Wochenschr 1992; 117(49): 1868-73.
[http://dx.doi.org/10.1055/s-2008-1062522] [PMID: 1459014]
[173]
Levelt E, Pavlides M, Banerjee R, et al. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes. J Am Coll Cardiol 2016; 68(1): 53-63.
[http://dx.doi.org/10.1016/j.jacc.2016.03.597] [PMID: 27364051]
[174]
Okura T, Nakata Y, Yamabuki K, Tanaka K. Regional body composition changes exhibit opposing effects on coronary heart disease risk factors. Arterioscler Thromb Vasc Biol 2004; 24(5): 923-9.
[http://dx.doi.org/10.1161/01.ATV.0000125702.26272.f6] [PMID: 15016639]
[175]
Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27(5): 996-1003.
[http://dx.doi.org/10.1161/ATVBAHA.106.131755] [PMID: 17303782]
[176]
Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988; 318(19): 1217-25.
[http://dx.doi.org/10.1056/NEJM198805123181901] [PMID: 3283552]
[177]
Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002; 105(15): 1861-70.
[http://dx.doi.org/10.1161/01.CIR.0000012467.61045.87] [PMID: 11956132]
[178]
Nelson MD, Victor RG, Szczepaniak EW, Simha V, Garg A, Szczepaniak LS. Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging. Am J Cardiol 2013; 112(7): 1019-24.
[http://dx.doi.org/10.1016/j.amjcard.2013.05.036] [PMID: 23800548]
[179]
Johannsen DL, Tchoukalova Y, Tam CS, et al. Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the “adipose tissue expandability” hypothesis. Diabetes Care 2014; 37(10): 2789-97.
[http://dx.doi.org/10.2337/dc14-0761] [PMID: 25011943]
[180]
Reitman ML. Metabolic lessons from genetically lean mice. Annu Rev Nutr 2002; 22: 459-82.
[http://dx.doi.org/10.1146/annurev.nutr.22.010402.102849] [PMID: 12055354]
[181]
Murakami D, Anan F, Masaki T, et al. Visceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes. J Diabetes Res 2019.20193129286
[http://dx.doi.org/10.1155/2019/3129286] [PMID: 31192262]
[182]
Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222(3): R113-27.
[http://dx.doi.org/10.1530/JOE-14-0283] [PMID: 25006217]
[183]
Scott HA, Gibson PG, Garg ML, Wood LG. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011; 38(3): 594-602.
[http://dx.doi.org/10.1183/09031936.00139810] [PMID: 21310876]
[184]
Ahangari F, Sood A, Ma B, et al. Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation. Am J Respir Crit Care Med 2015; 191(7): 746-57.
[http://dx.doi.org/10.1164/rccm.201405-0796OC] [PMID: 25629580]
[185]
Chu C, Li D, Zhang S, et al. Role of silibinin in the management of diabetes mellitus and its complications. Arch Pharm Res 2018; 41(8): 785-96.
[http://dx.doi.org/10.1007/s12272-018-1047-x] [PMID: 29978427]
[186]
Chu C, et al. Involvement of Estrogen Receptor-alpha in the Activation of Nrf2-Antioxidative Signaling Pathways by Silibinin in Pancreatic beta-Cells Biomol Ther (Seoul) 2019.
[187]
Linnemann AK, Neuman JC, Battiola TJ, Wisinski JA, Kimple ME, Davis DB. Glucagon-like peptide-1 regulates cholecystokinin production in β-cells to protect from apoptosis. Mol Endocrinol 2015; 29(7): 978-87.
[http://dx.doi.org/10.1210/me.2015-1030] [PMID: 25984632]
[188]
Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3(3): 153-65.
[http://dx.doi.org/10.1016/j.cmet.2006.01.004] [PMID: 16517403]
[189]
Lavine JA, Raess PW, Stapleton DS, et al. Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. Endocrinology 2010; 151(8): 3577-88.
[http://dx.doi.org/10.1210/en.2010-0233] [PMID: 20534724]
[190]
Rehfeld JF, Knop FK, Asmar A, Madsbad S, Holst JJ, Asmar M. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs. Scand J Gastroenterol 2018; 53(12): 1429-32.
[http://dx.doi.org/10.1080/00365521.2018.1530297] [PMID: 30449207]
[191]
Murphy PB, Vogt KN, Winick-Ng J, McClure JA, Welk B, Jones SA. The increasing incidence of gallbladder disease in children: A 20year perspective. J Pediatr Surg 2016; 51(5): 748-52.
[http://dx.doi.org/10.1016/j.jpedsurg.2016.02.017] [PMID: 26951963]
[192]
Khoo AK, Cartwright R, Berry S, Davenport M. Cholecystectomy in English children: evidence of an epidemic (1997-2012). J Pediatr Surg 2014; 49(2): 284-8.
[http://dx.doi.org/10.1016/j.jpedsurg.2013.11.053] [PMID: 24528968]
[193]
Walker SK, Maki AC, Cannon RM, et al. Etiology and incidence of pediatric gallbladder disease. Surgery 2013; 154(4): 927-31.
[http://dx.doi.org/10.1016/j.surg.2013.04.040] [PMID: 24074432]
[194]
Constantinou C, Sucandy I, Ramenofsky M. Laparoscopic cholecystectomy for biliary dyskinesia in children: report of 100 cases from a single institution. Am Surg 2008; 74(7): 587-92.
[PMID: 18646475]
[195]
Vegunta RK, Raso M, Pollock J, et al. Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery 2005; 138(4): 726-31.
[http://dx.doi.org/10.1016/j.surg.2005.06.052] [PMID: 16269302]
[196]
Lacher M, Yannam GR, Muensterer OJ, et al. Laparoscopic cholecystectomy for biliary dyskinesia in children: frequency increasing. J Pediatr Surg 2013; 48(8): 1716-21.
[http://dx.doi.org/10.1016/j.jpedsurg.2012.08.036] [PMID: 23932611]
[197]
Aune D, Vatten LJ. Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies. J Diabetes Complications 2016; 30(2): 368-73.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.11.012] [PMID: 26684168]
[198]
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004; 80(1): 38-44.
[http://dx.doi.org/10.1093/ajcn/80.1.38] [PMID: 15213025]
[199]
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 2006; 55(5): 708-14.
[http://dx.doi.org/10.1136/gut.2005.076133] [PMID: 16478796]
[200]
Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998; 128(6): 417-25.
[http://dx.doi.org/10.7326/0003-4819-128-6-199803150-00001] [PMID: 9499324]
[201]
Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med 1999; 341(11): 777-84.
[http://dx.doi.org/10.1056/NEJM199909093411101] [PMID: 10477775]
[202]
Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012; 35(9): 1835-44.
[http://dx.doi.org/10.2337/dc12-0002] [PMID: 22699290]
[203]
Boland LL, Folsom AR, Rosamond WD. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study. Ann Epidemiol 2002; 12(2): 131-40.
[http://dx.doi.org/10.1016/S1047-2797(01)00260-5] [PMID: 11880221]
[204]
Gitelson S, Oppenheim D, Schwartz A. Size of the gallbladder in patients with diabetes mellitus. Diabetes 1969; 18(7): 493-8.
[http://dx.doi.org/10.2337/diab.18.7.493] [PMID: 5795032]
[205]
Gitelson S, Schwartz A, Fraenkel M, Chowers I. Gall-bladder dysfunction in diabetes mellitus: The diabetic neurogenic gall bladder. Diabetes 1963; 12: 308-12.
[http://dx.doi.org/10.2337/diab.12.4.308] [PMID: 14081841]
[206]
Sahbaz NA, Peker KD, Kabuli HA, Gumusoglu AY, Alis H. Single center experience in laparoscopic treatment of gallbladder perforation. Wideochir Inne Tech Malo Inwazyjne 2017; 12(4): 372-7.
[http://dx.doi.org/10.5114/wiitm.2017.72321] [PMID: 29362652]
[207]
Niemeier OW. Acute Free Perforation of the Gall-Bladder. Ann Surg 1934; 99(6): 922-4.
[http://dx.doi.org/10.1097/00000658-193499060-00005] [PMID: 17867204]
[208]
Ausania F, Guzman Suarez S, Alvarez Garcia H, Senra del Rio P, Casal Nuñez E. Gallbladder perforation: morbidity, mortality and preoperative risk prediction. Surg Endosc 2015; 29(4): 955-60.
[http://dx.doi.org/10.1007/s00464-014-3765-6] [PMID: 25159627]
[209]
Ong CL, Wong TH, Rauff A. Acute gall bladder perforation--a dilemma in early diagnosis. Gut 1991; 32(8): 956-8.
[http://dx.doi.org/10.1136/gut.32.8.956] [PMID: 1885081]
[210]
Dyakiv-Koreiba NI. Clinical and laboratory features of cholelithiasis in patients with type 2 diabetes by gender. Wiad Lek 2018; 71(3 pt 1): 534-6.
[PMID: 29783219]
[211]
Schnell O, Crocker JB, Weng J. Impact of HbA1c Testing at Point of Care on Diabetes Management. J Diabetes Sci Technol 2017; 11(3): 611-7.
[http://dx.doi.org/10.1177/1932296816678263] [PMID: 27898388]
[212]
Lian J, Liang Y. Diabetes management in the real world and the impact of adherence to guideline recommendations. Curr Med Res Opin 2014; 30(11): 2233-40.
[http://dx.doi.org/10.1185/03007995.2014.952716] [PMID: 25105305]
[213]
Crocker JB, Lee-Lewandrowski E, Lewandrowski N, Baron J, Gregory K, Lewandrowski K. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol 2014; 142(5): 640-6.
[http://dx.doi.org/10.1309/AJCPYK1KV2KBCDDL] [PMID: 25319979]
[214]
Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999; 22(11): 1785-9.
[http://dx.doi.org/10.2337/diacare.22.11.1785] [PMID: 10546008]
[215]
Miller CD, Barnes CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26(4): 1158-63.
[http://dx.doi.org/10.2337/diacare.26.4.1158] [PMID: 12663590]
[216]
Zhuang L, Su JB, Zhang XL, et al. Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes. PLoS One 2016; 11(9)e0162204
[http://dx.doi.org/10.1371/journal.pone.0162204] [PMID: 27606813]
[217]
Fraquelli M, Pagliarulo M, Colucci A, Paggi S, Conte D. Gallbladder motility in obesity, diabetes mellitus and coeliac disease. Dig Liver Dis 2003; 35(Suppl. 3): S12-6.
[http://dx.doi.org/10.1016/S1590-8658(03)00087-2] [PMID: 12974503]
[218]
de Miguel-Yanes JM, Mendez-Bailon M, Jimenez-Garcia R, et al. Open versus laparoscopic cholecystectomies in patients with or without type 2 diabetes mellitus in Spain from 2003 to 2013. HBPD INT 2016; 15(5): 525-32.
[http://dx.doi.org/10.1016/S1499-3872(16)60091-7] [PMID: 27733323]
[219]
Samanta S, Samanta S, Banik K, Baronia AK. Emphysematous pancreatitis predisposed by Olanzapine. Indian J Anaesth 2014; 58(3): 323-6.
[http://dx.doi.org/10.4103/0019-5049.135049] [PMID: 25024479]
[220]
Birgisson H, Stefánsson T, Andresdóttir A, Möller PH. Emphysematous pancreatitis. Eur J Surg 2001; 167(12): 918-20.
[http://dx.doi.org/10.1080/110241501753361613] [PMID: 11841083]
[221]
Grayson DE, Abbott RM, Levy AD, Sherman PM. Emphysematous infections of the abdomen and pelvis: A pictorial review. Radiographics 2002; 22(3): 543-61.
[http://dx.doi.org/10.1148/radiographics.22.3.g02ma06543] [PMID: 12006686]
[222]
Houghton PW, Donaldson LA, Jenkinson LR, Crumplin MK. Weight gain after cholecystectomy. Br Med J (Clin Res Ed) 1984; 289(6455): 1350.
[http://dx.doi.org/10.1136/bmj.289.6455.1350] [PMID: 6437547]
[223]
Yazdankhah Kenary A, Yaghoobi Notash A Jr, Nazari M, et al. Measuring the rate of weight gain and the influential role of diet in patients undergoing elective laparoscopic cholecystectomy: A 6-month follow-up study. Int J Food Sci Nutr 2012; 63(6): 645-8.
[http://dx.doi.org/10.3109/09637486.2011.644767] [PMID: 22229881]
[224]
Ali RB, Cahill RA, Watson RG. Weight gain after laparoscopic cholecystectomy. Ir J Med Sci 2004; 173(1): 9-12.
[http://dx.doi.org/10.1007/BF02914515] [PMID: 15732228]
[225]
Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 2013; 108(6): 952-8.
[http://dx.doi.org/10.1038/ajg.2013.70] [PMID: 23545713]
[226]
Chavez-Tapia NC, Kinney-Novelo IM, Sifuentes-Rentería SE, et al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol 2012; 11(1): 85-9.
[http://dx.doi.org/10.1016/S1665-2681(19)31490-5] [PMID: 22166565]
[227]
Juvonen T, Kervinen K, Kairaluoma MI, Kesäniemi YA. Effect of cholecystectomy on plasma lipid and lipoprotein levels. Hepatogastroenterology 1995; 42(4): 377-82.
[PMID: 8586372]
[228]
Luo J, Phillips L, Liu S, Wactawski-Wende J, Margolis KL. Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer. J Clin Endocrinol Metab 2016; 101(3): 1243-8.
[http://dx.doi.org/10.1210/jc.2015-3901] [PMID: 26760177]
[229]
Gandini S, Puntoni M, Heckman-Stoddard BM, et al. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila) 2014; 7(9): 867-85.
[http://dx.doi.org/10.1158/1940-6207.CAPR-13-0424] [PMID: 24985407]
[230]
Tsilidis KK, Capothanassi D, Allen NE, et al. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care 2014; 37(9): 2522-32.
[http://dx.doi.org/10.2337/dc14-0584] [PMID: 24898303]
[231]
Hatoum D, McGowan EM. Recent advances in the use of metformin: can treating diabetes prevent breast cancer? BioMed Res Int 2015.2015548436
[http://dx.doi.org/10.1155/2015/548436] [PMID: 25866793]
[232]
Schlesinger S, Aleksandrova K, Pischon T, et al. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol 2013; 24(9): 2449-55.
[http://dx.doi.org/10.1093/annonc/mdt204] [PMID: 23720454]
[233]
Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care 2010; 33(7): 1674-85.
[http://dx.doi.org/10.2337/dc10-0666] [PMID: 20587728]
[234]
Luo J, Chlebowski R, Liu S, et al. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 2013; 24(3): 577-85.
[http://dx.doi.org/10.1007/s10552-012-9996-8] [PMID: 22622863]
[235]
Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011; 128(3): 635-43.
[http://dx.doi.org/10.1002/ijc.25362] [PMID: 20473855]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 9
Year: 2020
Page: [931 - 948]
Pages: 18
DOI: 10.2174/1573399816666200305094727
Price: $65

Article Metrics

PDF: 30
HTML: 5
EPUB: 3
PRC: 5